English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Trending
+
Regulatory
B. D. Benavides
| Mar 18, 2026
Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+
Pharmaceuticals
Patient Daily
| Mar 22, 2026
BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+
Regulatory
Patient Daily
| Mar 20, 2026
Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+
Pharmaceuticals
Patient Daily
| Mar 22, 2026
FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
No Results
